Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.
Cancer Lett. 2011 Jul 1;306(1):85-91. doi: 10.1016/j.canlet.2011.02.035. Epub 2011 Mar 15.
Cancer Lett. 2011.
PMID: 21411223
Free PMC article.
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
Li X, Lu Y, Liang K, Hsu JM, Albarracin C, Mills GB, Hung MC, Fan Z.
Li X, et al.
Oncogene. 2012 Oct 4;31(40):4372-83. doi: 10.1038/onc.2011.608. Epub 2012 Jan 9.
Oncogene. 2012.
PMID: 22231447
Free PMC article.
Item in Clipboard
The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α.
Lu H, Liang K, Lu Y, Fan Z.
Lu H, et al.
Cancer Lett. 2012 Sep 1;322(1):78-85. doi: 10.1016/j.canlet.2012.02.012. Epub 2012 Feb 17.
Cancer Lett. 2012.
PMID: 22348829
Free PMC article.
Item in Clipboard
Cite
Cite